BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Sep 26, 16:00
BioInvent International EPS Diluted (Quarterly): -0.1959 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.1959 |
| March 31, 2024 | -0.1138 |
| December 31, 2023 | -0.139 |
| September 30, 2023 | -0.1001 |
| June 30, 2023 | -0.1275 |
| March 31, 2023 | -0.1075 |
| December 31, 2022 | -0.1126 |
| September 30, 2022 | -0.0939 |
| June 30, 2022 | 0.2923 |
| March 31, 2022 | -0.1245 |
| December 31, 2021 | -0.1529 |
| September 30, 2021 | -0.1239 |
| June 30, 2021 | -0.1166 |
| March 31, 2021 | -0.2317 |
| December 31, 2020 | 0.0842 |
| September 30, 2020 | -0.113 |
| June 30, 2020 | -0.2069 |
| March 31, 2020 | -0.1695 |
| December 31, 2019 | -0.2089 |
| September 30, 2019 | -0.1826 |
| June 30, 2019 | -0.182 |
| March 31, 2019 | -0.2145 |
| December 31, 2018 | -0.2443 |
| September 30, 2018 | -0.1648 |
| June 30, 2018 | -0.3405 |
| Date | Value |
|---|---|
| March 31, 2018 | -0.2425 |
| December 31, 2017 | -0.3238 |
| September 30, 2017 | -0.211 |
| June 30, 2017 | -0.2226 |
| March 31, 2017 | -0.1921 |
| December 31, 2016 | -0.0542 |
| September 30, 2016 | -0.2875 |
| June 30, 2016 | -0.2984 |
| March 31, 2016 | 0.0058 |
| December 31, 2015 | -0.3746 |
| September 30, 2015 | -0.404 |
| June 30, 2015 | -0.5527 |
| March 31, 2015 | -0.5597 |
| December 31, 2014 | -0.8242 |
| September 30, 2014 | -0.294 |
| June 30, 2014 | 0.1375 |
| March 31, 2014 | -0.6978 |
| December 31, 2013 | 0.8812 |
| September 30, 2013 | -0.5951 |
| June 30, 2013 | -0.4064 |
| March 31, 2013 | -0.605 |
| December 31, 2012 | -0.8413 |
| September 30, 2012 | -1.430 |
| June 30, 2012 | -3.504 |
| March 31, 2012 | -1.572 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.2317
Minimum
Mar 2021
0.2923
Maximum
Jun 2022
-0.1122
Average
-0.1242
Median
EPS Diluted (Quarterly) Benchmarks
| Abliva AB | -0.0019 |
| Karolinska Development AB | -0.0056 |
| Calliditas Therapeutics AB | -0.165 |
| Oncopeptides AB | -0.0417 |
| Hansa Biopharma AB | -0.3094 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.87M |
| Revenue (Quarterly) | 0.4323M |
| Total Expenses (Quarterly) | 14.34M |
| Enterprise Value | 209.26M |
| Profit Margin (Quarterly) | -2.98K% |
| Earnings Yield | -11.68% |
| Normalized Earnings Yield | -12.55 |